Sugar substitutes under scrutiny: could they harm blood sugar control?
NCT ID NCT07124585
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how two common artificial sweeteners, sucralose and saccharin, affect blood sugar control and gut bacteria in adults with type 2 diabetes. Over 33 participants will take each sweetener or a placebo for one week, with breaks in between. The goal is to see if these sweeteners change insulin sensitivity and gut health, helping guide future dietary advice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 33 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Jul 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 50 years
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria This study aims to recruit a cohort of patients with early-phase diagnosed T2DM whose conditions are stable that can best represent the Malaysian DM phenotypes. 1. Male citizens of Malaysia. 2. Aged between 30 and 59 years. 3. BMI between 23-29.9 kg/m² (Overweight). 4. Diagnosed with diabetes for a duration between 1-10 years. 5. Currently on oral antidiabetic medications and not on insulin. 6. Initial HbA1c less than 10%. 7. Patients with other stable, non-severe chronic conditions (e.g., hypertension, dyslipidemia) may be included if they have been on a stable prescribed oral treatment for at least 6 months. 8. Patients who have undergone dietary counselling for diabetes and are willing to maintain their habitual diabetes-friendly diet and usual physical activity patterns throughout the study period. 9. Willing to refrain from alcohol throughout the study period. 10. Must be literate in English or Bahasa Malaysia. Exclusion criteria The exclusion criteria will primarily focus on lifestyle behaviours or dietary practices that deviate from typical Malaysian lifestyles and while also considering behaviours that could significantly alter the gut microbiota. 1. Current smoking, alcohol use, or drug abuse. 2. Experienced more than a 5% change in body weight within the past 3 months. 3. Acute illness or significant cardiovascular, psychological, neurological, renal, or endocrine diseases, apart from diabetes. 4. Intolerance or allergy to test products. 5. Special dietary practices (e.g., intermittent fasting, vegetarian, ketogenic diet) that deviate from typical Malaysian dietary patterns. 6. Treatment with glucocorticoids, antibiotics or other medications and food supplements (e.g. probiotics) that can significantly alter intestinal function and gut microbiome. 7. Involvement in clinical trials within the last 3 months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Type 2 diabetes mellitus (T2DM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Klinik Kesihatan Setapak
Kuala Lumpur, 53300, Malaysia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Four pills, one goal: can a new combo tame type 2 diabetes?
- Can banding the gut tame type 2 diabetes?
- Can QR codes and videos teach better foot care?
- Can a new injection help tackle obesity? a trial puts MWN105 to the test
- Can when you eat change how a diabetes drug works?
- Can a new daily pill outperform semaglutide for diabetes?